Nature of Operations and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Components of Inventories

The components of inventories are as follows:

	December 31,		December 31,
(In millions)	2022		2021
Raw materials	$	2,405	$	1,922
Work in process	660		676
Finished goods	2,569		2,453
Inventories	$	5,634	$	5,051

Schedule of Property, Plant and Equipment

Property, plant and equipment consists of the following:

	December 31,		December 31,
(In millions)	2022		2021
Land	$	454	$	431
Buildings and improvements	3,153		2,575
Machinery, equipment and leasehold improvements	7,967		7,020
Construction in progress	2,695		2,567
Property, plant and equipment, at cost	14,269		12,593
Less: Accumulated depreciation and amortization	4,989		4,260
Property, plant and equipment, net	$	9,280	$	8,333

Schedule of Acquisition-related Intangible Assets

Acquisition-related intangible assets are as follows:

	Balance at December 31, 2022						Balance at December 31, 2021
(In millions)	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Definite lived:
Customer relationships	$	21,792	$	(8,330)	$	13,462	$	22,802	$	(7,792)	$	15,010
Product technology	5,882		(4,360)		1,522		6,041		(3,977)		2,064
Tradenames	1,635		(1,008)		627		1,722		(919)		803
Backlog	1,038		(442)		596		1,060		(59)		1,001
	30,347		(14,140)		16,207		31,625		(12,747)		18,878
Indefinite lived:
Tradenames	1,235		N/A		1,235		1,235		N/A		1,235
Acquisition-related intangible assets	$	31,582	$	(14,140)	$	17,442	$	32,860	$	(12,747)	$	20,113

Schedule of Indefinite-Lived Acquisition-related Intangible Assets

Acquisition-related intangible assets are as follows:

	Balance at December 31, 2022						Balance at December 31, 2021
(In millions)	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Definite lived:
Customer relationships	$	21,792	$	(8,330)	$	13,462	$	22,802	$	(7,792)	$	15,010
Product technology	5,882		(4,360)		1,522		6,041		(3,977)		2,064
Tradenames	1,635		(1,008)		627		1,722		(919)		803
Backlog	1,038		(442)		596		1,060		(59)		1,001
	30,347		(14,140)		16,207		31,625		(12,747)		18,878
Indefinite lived:
Tradenames	1,235		N/A		1,235		1,235		N/A		1,235
Acquisition-related intangible assets	$	31,582	$	(14,140)	$	17,442	$	32,860	$	(12,747)	$	20,113

Schedule of Future Amortization Expense

The estimated future amortization expense of acquisition-related intangible assets with definite lives as of December 31, 2022 is as follows:

(In millions)
2023	$	2,279
2024	1,863
2025	1,582
2026	1,322
2027	1,296
2028 and thereafter	7,865
Estimated future amortization expense of definite-lived intangible assets	$	16,207

Schedule of Changes in Carrying Amount of Goodwill

The changes in the carrying amount of goodwill by segment are as follows:

(In millions)	Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Total
Balance at December 31, 2020	$	8,590	$	5,079	$	3,370	$	9,002	$	26,041
Acquisitions	1,560		56		8		14,400		16,024
Currency translation	(7)		(92)		(101)		59		(141)
Balance at December 31, 2021	10,143		5,043		3,277		23,461		41,924
Acquisitions	—		24		—		—		24
Finalization of purchase price allocations for 2021 acquisitions	9		—		—		168		177
Currency translation	(6)		(102)		(186)		(635)		(929)
Balance at December 31, 2022	$	10,146	$	4,965	$	3,091	$	22,994	$	41,196